News
News Home
Quick Bites
Exploradio
News Archive
News Channel
Special Features
NPR
nowplaying
On AirNewsClassical
Loading...
  
School Closings
WKSU Support
Funding for WKSU is made possible in part through support from the following businesses and organizations.

The Holden Arboretum


For more information on how your company or organization can support WKSU, download the WKSU Media Kit.

(WKSU Media Kit PDF icon )


Donate Your Vehicle to WKSU

Programs Schedule Make A Pledge Member BenefitsFAQ/HelpContact Us
Health and Medicine




Exploradio: Vaccines 2.0
A breakthrough in vaccine technology could provide protection against cancer, arthritis, and AIDS, but funding new vaccine testing is a major hurdle
by WKSU's JEFF ST. CLAIR
This story is part of a special series.


Reporter / Host
Jeff St. Clair
 
Dr. Kenneth Rosenthal is co-author of the Microbiology textbook used at NeoMed, and a professor of immunology. He co-discovered a novel mechanism for controlling the immune response and is testing new vaccines for breast cancer, Herpes Simplex virus, rheumatoid arthritis and HIV.
Courtesy of Jeff St.Clair
Download (WKSU Only)
In The Region:

The Centers for Disease Control expects 145 million flu shots will be given out this season.   Those vaccines -- for the flu and more than a dozen diseases  from polio to hepatitis -- are a big part of our strategy for disease prevention.

But developing vaccines for diseases like cancer, arthritis, or AIDS is proving more difficult.

In this week’s Exploradio, WKSU’s Jeff St.Clair finds that a new type of vaccine technology could change all that.

Exploradio: Vaccines 2.0

Other options:
Windows Media / MP3 Download (4:29)


(Click image for larger view.)

From smallpox to HPV
The idea of inoculation dates back to the 1500’s in China, where healthy people, given a dose of small pox, contracted a mild case of the disease and gained lifelong immunity.  In 18th century England, Edward Jenner’s experiments fighting small pox with inoculations of cow pox led to the science of immunology.  

The 20th century saw vaccines developed for diphtheria, pertussis, tetanus, polio, mumps, rubella, and hepatitis.  The human papillomavirus vaccine to fight cervical cancer came out three years ago.

But Ken Rosenthal, an immunology researcher at the Northeast Ohio Medical University, says producing new vaccines is an increasingly uphill battle.

“It takes a billion dollars to take a vaccine like that to market.”

A great LEAPS forward
Testing is expensive and time consuming.  A vaccine must be proven safe. It has to work on enough people to be effective.  And inoculations only protect against a few types of infections.

But Rosenthal says new discoveries in immunology are allowing his team at NEOMED to develop vaccines that someday could prevent a new range of diseases.

“This vaccine is for Herpes simplex virus,” Rosenthal says as he rummages around in a freezer in his lab. “And another one here is for the breast cancer vaccine; we also have one for HIV in this freezer, and we have the rheumatoid arthritis one in there as well.”  

Unlike traditional vaccines, these new vaccines trigger the immune response without introducing the disease.  They work through an alternative approach he calls LEAPS.

“Ligand Epitope Antigen Presentation System - when you’re from Akron you make acronyms.”

LEAPS, he says, fights infections by re-programming the cells that orchestrate the body’s immune response. 

“These vaccines will trigger the development of a very important white blood cell, so that it becomes the optimal white blood cell to initiate and direct the subsequent immune responses. It’s called the dendritic cell.”

Controlling the immune response
Dendritic cells hang out in parts of your body where infections can start, like blood vessels in your skin, lungs, or lymph glands.  When a virus or a foreign cell part floats by, the dendritic cells decide whether to initiate an attack, or let it pass.  Rosenthal say LEAPS allows him to control that process.

“So we create the dendritic cells that direct the immune response properly, and they do it.”

The dendritic cell’s weapon of choice is the immune system’s highly adaptable and effective T-cell.

“If you can get the dendritic cells in the right form, they will direct the T-cells of the person to do the job.”

The LEAPS vaccine creates immunity at the top of the immune cascade, without infecting the person, or causing inflammation.

Instead of creating antibodies for every possible mutation of a virus, the LEAPS vaccine teaches T-cells to recognize broad types of invaders.   

T-cells can also be programmed to destroy harmful tissue disguised as our own self, like tumor cells,

“and then not only attack from different sides of the tumor cell, but also work in different kinds of people who may recognize different parts of a protein because of their particular immune system.”

Keeping the balance in the body
Back in his lab, Rosenthal says the immune system is not just an army ready to attack; it’s a balance we maintain.  And every person is different.

“To be healthy we have to have a balance between the inflammatory and the repair mechanisms in the body.  In some people, the balance favors inflammation and for some people it favors repair.”

He says by helping the body achieve a healthy balance of immune responses, his new vaccines can not only prevent, but even treat ,auto-immune diseases like rheumatoid arthritis.

Still, only one LEAPS vaccine, for Herpes Simplex virus, is being commercially developed through a Virginia-based company called CEL –SCI, which has licensed the technology.

Rosenthal says his work represents what’s possible rather than what’s likely, at least for now.

“It’s still pie in the sky, something we’re looking for, aspiring toward but we’re not there yet.”

He won’t even hazard a guess on when the new vaccines could reach clinical trials, or where the billion dollars to complete the testing could come from.
Add Your Comment
Name:

Location:

E-mail: (not published, only used to contact you about your comment)


Comments:




 
Page Options

Print this page

E-Mail this page / Send mp3

Share on Facebook



Support for Exploradio
provided by:








Stories with Recent Comments

What's it take to take control of cancer?
In the case of bowel/colorectal cancer, the surest method of prevention is to have a colonoscopy, during which pre-cancerous "polyps" are removed - https://t.co...

Western Stark Free Clinic is set to close but to continue its role
WHAT OTHER DENTAL CLINICS AND MEDICAL CLINICS ARE IN THE CANTON AND MASSILLON, OHIO AREAS?

Three exonerated of murder convictions from 18 years ago
Thanks heavens that none of them have been condemned to death. This alons should convince the USA to join the civilized world by abolishing the death penalty. E...

Kombucha: a sweet business brewed with fermented tea
Stevia is not an artificial sweetener. It is a plant. I have one growing in my sunroom. The leaves are dried and added to teas. It's harvested commercially and...

Bringing back ballet in Cleveland
I do think Ballet in Cleveland is doing good things, but the fact that director says "When we have flourishing companies like the New York City Ballet and the A...

Report confirms some Vietnam veterans may have been exposed to Agent Orange
was in nam 1969 exposed va stated lost medical records was in lawsuit from 197? till settled 0 $ 2010 ? said all nam vets will get back disability till 198? jus...

Mentorship grant program redefines "faith-based" provision
Can't anyone have values, beliefs, and morals anymore? How is it anymore unconstitutional for a school partner with a "faith-based" organization than any other ...

Exploradio: The challenge of finding a healthy balance with technology
Thank you, Jeff, for another well done Exploradio. I always learn something interesting about what is happening in NE Ohio.

Northeast Ohio's transgender community rallies around restroom issue
A good first step would be for Cleveland to require restaurants to have a public restroom. Cleveland is the only city I've ever been in where restaurants somet...

Copyright © 2015 WKSU Public Radio, All Rights Reserved.

 
In Partnership With:

NPR PRI Kent State University

listen in windows media format listen in realplayer format Car Talk Hosts: Tom & Ray Magliozzi Fresh Air Host: Terry Gross A Service of Kent State University 89.7 WKSU | NPR.Classical.Other smart stuff. NPR Senior Correspondent: Noah Adams Living on Earth Host: Steve Curwood 89.7 WKSU | NPR.Classical.Other smart stuff. A Service of Kent State University